# US 2023/0310719 A1 · Phase Change Material for Thermal Therapy and Delivery of Active Ingredients

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0310719 A1
- Document ID: US20230310719A1
- Status: Published application
- Kind: A1
- Application number: 18/206,322
- Filed: 2023-06-06
- Published: 2023-10-05
- Earliest claimed: 2014-08-22
- Assignees: Alps South, LLC
- Applicants: Alps South, LLC
- Inventors: Aldo Laghi
- Web page: https://patentgrep.com/patent/US20230310719A1

## CPC

- A45D 44/002: {Masks for cosmetic treatment of the face}
- A61L 31/16: Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)}
- A45D 37/00: Sachet pads specially adapted for liquid toiletry or cosmetic substances
- A45D 44/10: Head-rests; Neck-rests
- A45D 44/22: Face shaping devices, e.g. chin straps; Wrinkle removers, e.g. stretching the skin (skin stretchers for shaving A45D27/38)
- A61F 13/00063: {comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic (drug delivery dressings A61K9/70; chemical aspect of the additives A61L15/00)}
- A61K 8/0208: {Tissues; Wipes; Patches}
- A61K 8/0212: {Face masks}
- A61K 8/90: Block copolymers (A61K8/89 takes precedence)
- A61K 31/4164: 1,3-Diazoles
- A61K 31/4174: Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
- A61K 31/522: having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
- A61K 31/546: containing further heterocyclic rings, e.g. cephalothin
- A61K 31/65: Tetracyclines
- A61K 31/7048: having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin {, digitoxin or digoxin}
- A61K 31/7052: having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K 31/7056: containing five-membered rings with nitrogen as a ring hetero atom
- A61K 31/79: Polymers of vinyl pyrrolidone
- A61L 15/20: containing organic materials
- A61L 15/24: Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof {(A61L15/225 takes precedence)}
- A61L 15/26: Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof {(A61L15/225 takes precedence)}
- A61L 15/34: Oils, fats, waxes or natural resins {(A61L15/225 takes precedence)}
- A61L 15/42: Use of materials characterised by their function or physical properties (liquid bandages A61L26/00)
- A61L 31/129: {containing macromolecular fillers}
- A61L 31/141: {Plasticizers}
- A61Q 19/00: Preparations for care of the skin
- B29C 39/003: {characterised by the choice of material}
- B29C 39/123: {Making multilayered articles}
- B32B 3/02: characterised by features of form at particular places, e.g. in edge regions {(non-uniform thickness B32B3/263)}
- B32B 3/08: characterised by added members at particular parts {(layer formed of separate pieces of material which are juxtaposed side-by-side B32B3/14, B32B3/18)}
- B32B 3/266: {characterised by an apertured layer, the apertures going through the whole thickness of the layer, e.g. expanded metal, perforated layer, slit layer regular cells B32B3/12}
- B32B 5/02: characterised by structural features of a {fibrous or filamentary} layer {(layer formed of metallic wires B32B15/02; layer formed of natural mineral fibres B32B19/02; layer formed of wood fibres B32B21/02)}
- B32B 5/024: {Woven fabric}
- B32B 5/026: {Knitted fabric}
- B32B 5/18: characterised by features of a layer {of} foamed material
- B32B 5/245: {another layer next to it being a foam layer}
- B32B 5/26: another layer {next to it} also being fibrous or filamentary {(relative arrangement of fibres or filaments of different layers B32B5/12)}
- B32B 7/06: permitting easy separation
- B32B 27/065: {of foam}
- B32B 27/12: next to a fibrous or filamentary layer
- B32B 27/306: {comprising vinyl acetate or vinyl alcohol (co)polymers}
- B32B 27/34: comprising polyamides
- C08L 25/08: Copolymers of styrene (C08L29/08, C08L35/06, C08L55/02 take precedence)
- A45D 2200/1036: containing a cosmetic substance, e.g. impregnated with liquid or containing a soluble solid substance
- A61F 2013/00187: {insulating; warmth or cold applying}
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- B32B 2250/03: 3 layers
- B32B 2250/04: 4 layers
- B32B 2262/0253: Polyolefin fibres
- B32B 2262/0261: Polyamide fibres
- B32B 2262/0276: Polyester fibres
- B32B 2262/062: Cellulose fibres, e.g. cotton
- B32B 2262/08: Animal fibres, e.g. hair, wool, silk
- B32B 2266/025: Polyolefin
- B32B 2266/0292: Thermoplastic elastomer
- B32B 2266/12: Gel
- B32B 2307/30: having particular thermal properties
- B32B 2307/304: Insulating
- B32B 2307/51: Elastic
- B32B 2307/718: Weight, e.g. weight per square meter
- B32B 2307/7376: Thickness
- B32B 2307/738: Thermoformability
- B32B 2535/00: Medical equipment, e.g. bandage, prostheses or catheter
- B32B 2555/00: Personal care
- A45D: HAIRDRESSING OR SHAVING EQUIPMENT (wigs, toupees or the like A41G3/00, A41G5/00; hairdressers' chairs A47C1/04; hair cutting appliances, razors B26B); EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- B29C: SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING (making preforms B29B11/00; making laminated products by combining previously unconnected layers which become one product whose layers will remain together B32B37/00 - B32B41/00)
- B32B: LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)

## Abstract

A method of manufacturing a therapeutic material incorporating a soft thermoformable elastomer with a phase change material exhibiting high latent heat of fusion. The compound provides elasticity, softness, formability, and heat over an extended duration and to facilitate prolonged skin contact at elevated temperatures. Used in combination with active ingredients the increased temperature and formability provides enhanced transdermal delivery through the skin. Thermoplastic elastomers may be manufactured by mixing together plasticizing oil, a triblock copolymer, a paraffinic substance and one or more additives, e.g., an antioxidant, an antimicrobial agent, and/or other additives to form a mixture which melted then cooled into the thermoplastic elastomer. During cooling, the thermoplastic elastomer may be molded or otherwise formed into any number of articles including, but not limited to, prosthetic liners, prosthetic sleeves, external breast prostheses, breast enhancement bladders, masks, wound dressing sheets, wound dressing pads, socks, gloves, malleolus pads, metatarsal pads, shoe insoles, urinary catheters, vascular catheters, and balloons for medical catheters both vascular as well as urinary. Active ingredients are preferably added to the cooling thermoplastic elastomer when the temperature is below 100° F. to prevent heat degradation and/or breakdown of vital proteins.

## Claims

### Claim 1

A method of manufacturing a therapeutic material comprising:
adding a heat-tolerant antioxidant, an active ingredient selected from the group consisting of acyclovir, azidothymidine, azithromycin, benzoyl peroxide, ceftriaxone, clindamycin, clotrimazole, doxycycline, erythromycin, metronidazole, nystatin, povidone iodine, and sulfasalazine, and a styrene block copolymer to a liquid plasticizing oil to make a first mixture;
heating the first mixture to between 350° F. and 400° F. to make a molten mixture;
pouring the molten mixture into a mold;
cooling the molten mixture to a temperature between 100° F. and 77° F. to create an elastomer wherein as the molten mixture cools between a temperature between 300° F. and 200° F. an additional active ingredient is added;
applying the elastomer to a treatment garment forming a composite; and
removing the composite from the mold.

### Claim 2 (depends on 1)

The method of manufacturing a therapeutic material of claim 1 wherein the plasticizing oil is selected from the group consisting of paraffinic oils, naphthenic petroleum oils, mineral oils, and synthetic liquid oligomers of polybutene, polypropylene, and polyterpene.

### Claim 3 (depends on 1)

The method of manufacturing a therapeutic material of claim 1 wherein the treatment garment further comprises an outer fabric layer and a thermoformable resin applied to the outer fabric layer prior to application of the elastomer.

### Claim 4 (depends on 3)

The method of manufacturing a therapeutic material of claim 3 wherein the thermoformable resin further comprises a mass from 110 to 160 grams.

### Claim 5 (depends on 1)

The method of manufacturing a therapeutic material of claim 1 wherein the treatment garment has an elasticity ranging from 80% to 140% in a vertical direction and 60% to 100% in the horizontal direction as compared to an un-stretched position.

### Claim 6 (depends on 1)

The method of manufacturing a therapeutic material of claim 1 wherein the thickness of the elastomer on the treatment garment after application ranges from 0.05 inches to 0.625 inches.

### Claim 7 (depends on 1)

The method of manufacturing a therapeutic material of claim 1 wherein the additional active ingredient is selected from the group consisting of acyclovir, azidothymidine, azithromycin, benzoyl peroxide, ceftriaxone, clindamycin, clotrimazole, doxycycline, erythromycin, metronidazole, nystatin, povidone iodine, and sulfasalazine.
